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Abstract
Background: Arrayed primer extension (APEX) is a microarray-based rapid minisequencing
methodology that may have utility in 'personalized medicine' applications that involve genetic
diagnostics of single nucleotide polymorphisms (SNPs). However, to date there have been few
reports that objectively evaluate the assay completion rate, call rate and accuracy of APEX. We
have further developed robust assay design, chemistry and analysis methodologies, and have sought
to determine how effective APEX is in comparison to leading 'gold-standard' genotyping platforms.
Our methods have been tested against industry-leading technologies in two blinded experiments
based on Coriell DNA samples and SNP genotype data from the International HapMap Project.
Results: In the first experiment, we genotyped 50 SNPs across the entire 270 HapMap Coriell
DNA sample set. For each Coriell sample, DNA template was amplified in a total of 7 multiplex
PCRs prior to genotyping. We obtained good results for 41 of the SNPs, with 99.8% genotype
concordance with HapMap data, at an automated call rate of 94.9% (not including the 9 failed
SNPs). In the second experiment, involving modifications to the initial DNA amplification so that a
single 50-plex PCR could be achieved, genotyping of the same 50 SNPs across each of 49 randomly
chosen Coriell DNA samples allowed extremely robust 50-plex genotyping from as little as 5 ng of
DNA, with 100% assay completion rate, 100% call rate and >99.9% accuracy.
Conclusion: We have shown our methods to be effective for robust multiplex SNP genotyping
using APEX, with 100% call rate and >99.9% accuracy. We believe that such methodology may be
useful in future point-of-care clinical diagnostic applications where accuracy and call rate are both
paramount.
Background
If 'personalized medicine', using genomic knowledge, is
to become a reality, then the ability to determine the most
appropriate clinical intervention for a patient will require
the genotyping of several tens to hundreds of single nucle-
otide polymorphisms (SNPs) across many genes and their
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idly and at the point-of-care. Of many genotyping meth-
ods, those based on microarrays offer the greatest
potential for economic, patient-specific application [3-7],
due to their ability to simultaneously interrogate multiple
SNPs. Arrayed primer extension (APEX [8,9]) is a minise-
quencing microarray assay based on a two-dimensional
array of oligonucleotide probes that are immobilized, via
their 5' ends, on a glass surface. The probes (25-mers) are
designed so that they are complementary to the gene up
to, but not including, the base where the SNP exists. The
Sanger-based sequencing chemistry of APEX allows geno-
typing of hundreds of SNPs, with the array chemistry tak-
ing only fifteen to twenty minutes to complete. APEX
achieves this clinically relevant speed because it uses the
catalytic ability of a DNA polymerase to carry out a single
nucleotide base extension (SBE) at the 3' end of the
arrayed probes, specific to the SNP sites of interest in
amplified patient DNA that is temporarily hybridized to
these probes. The dideoxynucleotide (ddNTP) 'termina-
tor' bases are labelled with tags containing distinct fluo-
rescent chromophores, specific for each of the four bases
of DNA (A,C,G,T). Hence, the fluorescent 'colour' at each
of the probe sites (array spots) will give SNP-specific gen-
otypic information. As a discovery research tool, APEX has
been used to detect β-thalassemia [10], p53 [11], and
BRCA1 mutations [12]. Importantly, APEX has also been
shown to be efficient at simultaneously genotyping SNP
markers that are widely dispersed across the human
genome [13,14]; such capability is essential for future
'individualized' genomic diagnostic analysis across multi-
ple genes and pathways that are relevant to disease. In a
recent quality assessment survey of SNP genotyping labo-
ratories [15], in which up to 18 SNPs were genotyped
across 47 DNA samples, APEX performed well against
other methods, and the authors concluded that a "con-
servative approach for calling the genotypes should be
used to achieve a high accuracy at the cost of a lower gen-
otyping success rate." Whilst such a conservative approach
may be applicable for research studies, it may not be
appropriate for clinical diagnostics, in which life-saving
medical decisions might require extremely accurate geno-
typing across all SNPs of interest.
Given the potential utility of APEX for rapid clinical diag-
nostics, we have developed robust assay design, chemistry
and analysis methodologies, and have sought to deter-
mine just how effective APEX is in comparison to leading
'gold-standard' genotyping platforms, including Perlegen
and Illumina. Our objective was to achieve 100% assay
completion rate, call rate and genotyping accuracy rate,
for multiple SNPs across multiple samples. Previous stud-
ies from our laboratory have reported APEX genotyping
accuracies ranging from 98% to 99.8% [14,16-18],
though the call rates in these studies have always been sig-
nificantly lower than 100%, and usually do not include a
proportion of the originally selected SNPs that fail the
assay. Similarly, other laboratories that use APEX and
equivalent technology have reported genotyping accura-
cies ranging from 98% to >99%, with call rates varying
from 84.4% to 96.8% [10,11,13,15,19-21].
Results and Discussion
We selected 50 SNPs from the HapMap database that had
been previously genotyped and analyzed as part of the
third quality control exercise on Illumina and Perlegen
platforms, arguably the most accurate and best validated
high-throughput methodologies for SNP genotyping to
date. The randomly selected SNPs were located across
multiple chromosomes and are listed in Additional file 1
online, along with details of the APEX probe sequences
and PCR primer sequences. The genotyping arrays that are
currently being developed and tested in our laboratory
incorporate multiple redundant measures consisting of
sense and antisense DNA-strand APEX probes plus allele-
specific oligonucleotide (ASO) APEX probes for a total of
six different probes per SNP [14], with each replicated five
times on the array grid, which allows for more robust sta-
tistical averaging. Optimal PCR primer pairs were
designed for each of the 50 SNP loci [Additional file 1]
and seven multiplex PCR groups were set up that,
together, would amplify all 50 loci [Additional file 2]. We
obtained a set of 287 DNA samples from McGill Univer-
sity and Génome Québec Innovation Centre (one of the
HapMap Project's genotyping centers). This set comprised
270 DNA samples from the Coriell Institute for Medical
Research [22] plus hidden duplicates and negative con-
trols, all of which our laboratory was blinded to. PCR [Fig.
1a and Fig. 1b] and APEX assays were performed on each
of the samples, plus a 10% repeat set which was randomly
selected by us to allow internal quality control and an ini-
tial assessment of genotyping concordance.
Microarray image data were imported into SNP Chart [23]
and analyzed using previously described image analysis
algorithms [24,25]. Genotypes were called using two pre-
viously published methods: 1. MACGT software [17],
which is a multi-dimensional clustering tool; 2. simple
linear discriminant analysis (LDA) using dynamic varia-
ble selection [18], which is a classification algorithm.
Results are shown in Table 1 and Additional file 3 online.
Briefly, a training set was established using SNP Chart, fol-
lowed by auto-calling in MACGT. Nine SNPs did not pass
quality control due to assay failure or inconsistent PCR
amplification. For all remaining SNPs that were auto-
called by MACGT, any genotypes that had a 'fit' score of
less than 0.001 (approximately 9%) were checked by
manual scoring in SNP Chart and either validated, or
changed to a different genotype or to a non-call (NN). The
final results using MACGT showed highly accurate geno-Page 2 of 15
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call rates (90% auto-called plus 9% manual scoring).
Importantly, of the 1,013 genotypes called manually, the
accuracy was 99.87%, even in cases where the array spot
signal intensities were up to an order of magnitude lower
than for higher quality genotype data, and only slightly
higher than background signals [Additional file 4 and
Additional file 5]. Using the same training set, we then
analyzed the data set with simple linear discriminant
analysis (LDA) using dynamic variable selection [18].
Results [Table 1 and Additional file 3] also showed accu-
rate genotyping (99.91% HapMap concordance), and
with higher automated call-rates (94.91% – using a confi-
dence score threshold of 0.75). We also calculated the
homozygous and heterozygous performance for the set of
270 HapMap samples with the previously selected 41
SNPs out of 50 SNPs [See Table 1]. For a threshold of 0.75,
we were able to call 6883 cases out of 7214 homozygous
cases (95.41% call rate) with 6880 correct calls (99.96%
HapMap concordance). Whereas, with the same thresh-
old, out of 3873 heterozygous cases, we were able to call
3640 cases (93.98% call rate) with 3634 correct calls
(99.84% HapMap concordance). Therefore, in common
with other genotyping platforms, our methodology has a
slight bias that favours the calling of homozygous geno-
types.
Multiplexing PCR and subsequent amplicon fragmentation results, prior to APEX reaction on HapMap ChipFigure 1
Multiplexing PCR and subsequent amplicon fragmentation results, prior to APEX reaction on HapMap Chip. (a) Standard mul-
tiplex PCR from a single Coriell DNA sample using optimally-designed primers [Additional files 1 &2] within seven unique mul-
tiplex groups (lanes 1–7; lane M shows 100 bp DNA ladder markers), showing wide range of amplicon sizes across the 50 SNP 
loci. (b) Purification, concentration and fragmentation of standard PCR amplicons. Lane 1 represents an aliquot of concen-
trated mixture of all seven multiplex products shown in Fig. 1a. Lane 2 shows the fragmentation result, generating single-
stranded nucleic acid of 30–100 base length. (c) Multiplex PCR amplification of all 50 SNP loci in a single reaction tube using 
new PCR primer set [Additional file 6], showing 50-plex PCR products (individual SNP loci amplicons are unresolvable by aga-
rose gel electrophoresis) from two Coriell DNA samples (lanes 1 & 2), plus a negative PCR control (lane 3). (d) Fragmentation 
of 50-plex PCR amplicons from aliquots of lane 1 & lane 2 samples shown in Fig. 1c.Page 3 of 15
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as any previously reported for APEX-based methodolo-
gies, did not deliver on our objective of 100% call rate and
100% accuracy, and several of the 50 SNPs failed quality
control. However, two important lessons were learnt from
the study: 1. our on-chip assay chemistry is extremely
robust and specific, allowing accurate genotype calls (at
least by manual inspection of the array spot data within
SNP Chart) even at very low sensitivities (i.e., when the
sequence-specific spot intensities are only slightly higher
than background signals); 2. non-calls (NNs) generally
resulted from sporadic PCR failure for certain amplicons,
especially those of a length greater than 650–700 base
pairs (bp). Taken together, our results suggested that even
if specific SNPs give high NN rates across multiple sam-
ples, the genotypes for the remaining samples for these
SNPs (for which APEX assay data can be obtained) are still
very accurate, despite low signal to noise. We believe that
this is due to the redundancy in the genotyping probe
design: two classical APEX probes (one probe per DNA
strand), plus four allele-specific (ASO) APEX probes (two
probes per strand), each replicated five times, for each
SNP site. When this redundant data is displayed in a SNP
Chart, it is relatively straightforward to interpret the geno-
type manually [Additional file 4 and Additional file 5].
From these conclusions we reasoned that the PCR design
itself needed to be addressed, so that sporadic failures
(despite good primer design algorithms) could be consist-
ently minimized or even eliminated.
For SNP genotyping, only the immediate sequence
around the SNP site is of interest. Therefore, keeping the
PCR amplicon size to a minimum ensures short extension
times and minimal use of reagents. However, sequence-
context issues, especially in multiplex PCR, necessitate the
design of unique primers that have balanced annealing
temperatures. This requirement can result in individual
amplicon sizes in a multiplex mix ranging from 100 to
>700 bp [14]. Large amplicons are optimal neither for fast
PCR nor for the subsequent APEX assay, which requires
amplicons to be fragmented to ~50–100 base lengths [Fig.
1b]. In addition, the degree of multiplexing is usually lim-
ited to between four and ten amplicons per individual
multiplex PCR: e.g., for our original HapMap chip, the 50
SNP loci are amplified in a total of seven separate multi-
plex reactions [Fig. 1a and Additional file 2]. We initially
tested multiplex PCR using all original PCR amplicon
primer pairs in a single reaction. As expected, several
experimental attempts all failed to amplify even a modest
proportion of the 50 amplicons (typically, less than 20
amplicons would be successful; data not shown). Thus,
our new objectives were to increase the degree of multi-
plexing and shorten the amplicon lengths to less than 200
bp, so that all 50 SNP loci could be simultaneously and
robustly amplified in a single reaction vessel. New PCR
primers were designed for the 50 HapMap SNP loci, with
amplicon sizes restricted to between 100 and 200 bp
[Additional file 6]. Because of this limitation, we were not
able to optimally design the primers based on a balanced
melting temperature (Tm). To try to compensate for this
potential problem, each new PCR primer had a common
linker sequence designed at its 5' end (5' TACGACTCACT-
TAGGGAG 3' for each of the left hand PCR primers/5'
CGATGTAGGTGACACTAG 3' for each of the right hand
PCR primers). These linkers have two properties: a bal-
anced and reasonably high GC content to increase the
melting temperature of the primer and a unique sequence
not found in the human DNA template [26]. After the first
few cycles of PCR, the linker sequence becomes incorpo-
rated into the amplicon sequence and is amplified along
with the template sequence. This approach helps reduce
primer-dimer formation during the PCR [27]. Because the
primers have balanced GC content, primer annealing in
later cycles of PCR should become much more sensitive
and robust [28]. We randomly selected 50 of the HapMap
Coriell DNA samples from our initial study, for 50-plex
PCR using the pool of linker-modified primers. Specific
PCR cycling conditions were adopted from a previously
published study by Wang et al. [28]. We also attempted
50-plex PCR using the redesigned PCR primers, but with-
out the common 5' linker sequences: we managed to
amplify only a modest number of the 50 SNPs, and this
multiplex PCR was not robust and we could never amplify
all 50 SNPs (data not shown).
PCR [Fig. 1c and Fig. 1d] and APEX assays [Fig. 2] were
performed on each of the samples, including negative
controls. Microarray image data were imported into SNP
Chart and analyzed as described previously. Genotype
calling was performed using three independent methods:
1. manual calling in SNP Chart; 2. auto-calling with
MACGT; and 3. auto-calling by LDA using dynamic varia-
Table 1: Results summary for 287 HapMap samples and 41 SNPs
Method Call rate Concordance with HapMap
MACGT (0.001 cut-off) + manual calls 98.90% (9% manual calls) 99.94%
LDA (0.75 threshold) Total cases 94.91% (10,523 cases vs. 11,087) 99.91% (10,514 vs. 10,523)
LDA (0.75 threshold) Homozygous cases 95.41% (6,883 vs. 7,214) 99.96% (6,880 vs. 6,883)
LDA (0.75 threshold) Heterozygous cases 93.98% (3,640 vs. 3,873) 99.84% (3,634 vs. 3,640)Page 4 of 15
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for concordance. One SNP (rs7693776) was monomor-
phic (TT) across all samples genotyped. Results are pre-
sented in Table 2 and [Additional files 7, 8, 9, 10]. Manual
genotype calling, although time-consuming and vulnera-
ble to user-subjectivity issues [14,23], is nevertheless an
accurate and validated way to interpret APEX data, espe-
cially at low spot intensity levels (see above). In addition,
manual calling does not require the use of a training set.
Of the 49 Coriell DNA samples (one sample out of the
random set was a blinded negative control sample)
assayed across 50 SNPs, manual calls were made for all
possible 2,450 genotypes (100% assay completion and
100% call rate). Of these, 2,448 were concordant with
HapMap data (99.92%). The two discrepant genotypes
were for two different samples each at different SNP loci.
Interestingly, the SNP Charts for these two genotypes
showed high quality data, and the same samples/geno-
types had previously been concordant with HapMap in
the initial data set [Additional file 3, and discussed further
below].
Auto-calling was independently undertaken. Initially,
MACGT cluster plots and quality control using SNP Chart
Table 2: Results summary for 49 HapMap samples and 50 SNPs
Method Call rate Concordance with HapMap
Manual calling only 100% 99.92%1
MACGT (no cut-off) 100% 99.84%2
LDA (0 threshold) Total cases 100% (1,941 cases vs. 1,941) 99.89%3 (1,939 vs. 1,941)
LDA (0 threshold) Homozygous cases 100% (1,289 vs. 1,289) 100%4 (1,289 vs. 1,289)
LDA (0 threshold) Heterozygous cases 100% (652 vs. 652) 99.7%5 (650 vs. 652)
MACGT (0.001 cut-off) 94.04% 99.94%6
LDA (0.65 threshold) Total cases 99.18% (1,925 vs. 1,941) 99.90%3 (1,923 vs. 1,925)
LDA (0.65 threshold) Homozygous cases 98.91%7 (1,275 vs. 1,289) 100% (1,275 vs. 1,275)
LDA (0.65 threshold) Heterozygous cases 99.7% (650 vs. 652) 99.7% (648 vs. 650)
1 Two discrepancies amongst 2,450 genotype cases.
2 Three discrepancies amongst 1,926 genotype cases (524 cases used in training set).
3 Two discrepancies amongst 1,941 genotype cases (509 cases used in training set).
4 No discrepancy amongst 1289 cases (327 cases used in training set)
5 Two discrepancies amongst 652 cases (182 cases used in training set)
6 One discrepancy amongst 1,926 genotype cases (524 cases used in training set).
7 Eleven predictions (all TT and correct) with confidence score less than 0.65 for a single SNP (rs1891403).
HapMap Chip four colour microarray images showing successful de-multiplexing of 50-plex PCR from two Coriell DNA sam-ples (a, b), plus a negative control s mple (c), prior to image analysis and automated genotypingFigure 2
HapMap Chip four colour microarray images showing successful de-multiplexing of 50-plex PCR from two Coriell DNA sam-
ples (a, b), plus a negative control sample (c), prior to image analysis and automated genotyping. The spots on the negative 
control image represent positive control probes [8, 14].Page 5 of 15
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set of samples from the data set [17]. Using this training
set, MACGT auto-calling of the test set with a 0.001 fit
threshold resulted in a call rate of 94.04% and a concord-
ance rate of 99.94%. When the fit threshold was relaxed to
achieve a 100% call rate, three genotypes were discordant
with HapMap data. Two of these genotypes (both with
high fit values – good confidence scores) were the same as
the two that had been identified as part of the manual call-
ing data. The third discrepancy had a relatively poor fit
confidence score. LDA with dynamic variable selection,
using a slightly reduced sized training set, yielded identi-
cal genotyping results to manual calling, at a 100% call
rate across all 50 SNPs (16 NNs at a 0.65 confidence score
threshold). Again, the two discrepant genotypes, both of
which were incorrectly called as homozygous, had high
confidence scores, consistent with high quality APEX
assay data. Separate analysis of homozygous and hetero-
zygous cases showed that for a 0.0 threshold,
homozygous cases (1289 in total) achieved a call rate of
100% with 100% HapMap concordance, whereas hetero-
zygous cases (652 in total) achieved a call rate of 100%
with 99.7% HapMap concordance (two heterozygous
errors with high confidence scores). Surprisingly, with a
0.65 threshold, among 16 non-calls 14 were homozygous
with 11 cases (all TT genotypes) from a single SNP
rs1891403, which gives a homozygous call rate of 98.9%
and a heterozygous call rate of 99.7%. Interestingly, the
LDA-called genotype that had the lowest score (but never-
theless was still called correctly) was the same genotype as
the third MACGT-called discordant genotype [see above
and Additional file 7]. Subsequent inspection of the SNP
Chart for this genotype (heterozygous CT) showed that
the ASO-APEX probe intensity signals for the C allele were
somewhat lower than the T allele signals. Again, this same
sample/genotype had previously been concordant with
HapMap in the initial data set, using the original PCR
primer pairs. (See below for further discussion of this gen-
otype and the other two discrepant genotypes.)
In summary, we have shown that a combination of multi-
plex PCR, redundant and robust APEX design and assay,
and statistically-robust auto-calling (simple LDA using
dynamic variable selection) can achieve 100% comple-
tion and call rate with >99.9% accuracy, for multiple SNPs
and multiple samples. We believe that this is a significant
improvement over other published APEX methodologies.
The strength of our methodology is not based on the qual-
ity of a single measurement but on the redundancy
obtained from measuring the allele intensities by using
multiple chemistries. To take advantage of this inherent
robustness of the assay we use robust statistical methods
that automatically select the most reliable measurements
for each SNP to make the genotype call, sample by sample
[18]. Redundancy in genotyping arrays is associated with
higher costs per SNP, concomitant with lower numbers of
SNPs able to be interrogated in a given area of the micro-
array. For research studies, a trade-off may need to be
taken into consideration, given the ever-increasing need
to genotype as many SNPs as possible, at minimal cost per
SNP, and a recent article by Smemo and Borevitz [29]
cogently argues for a reduction in the approximately 40-
fold probe redundancy currently featured on Affymetrix
GeneChips, which only use hybridization for allelic signal
generation. For clinical diagnostics however, we believe
that genotyping accuracy, call rate and completion rate are
paramount.
To further determine the effect of probe redundancy in
our APEX methodology, we used LDA to reanalyze both
data sets (original and 50-plex) but using non-redundant
and partially-redundant probe-specific data [Additional
files 8, 9 and 10]. Fig. 3 and Additional file 11 show sim-
ple four-panel scatter plots of the probe data for the 50-
plex experiment. In particular, Fig. 3 represents the four
separate scatter plots for the SNP rs12466929 correspond-
ing to the four different probe chemistries: ASO.LEFT,
ASO.RIGHT, APEX.LEFT and APEX.RIGHT. For each scat-
ter plot, the three possible genotype clusters (previously
known from the HapMap data set) are presented with
three different colours: blue for allele 1 homozygous;
magenta for allele 2 homozygous; and green for allele 1
and allele 2 heterozygous. For the SNP rs12466929, allele
1 is A and allele 2 is G, and the scatter plots are represent-
ative of the entire set of 50 HapMap SNPs. The four scatter
plots indicate that three out of the four probe chemistries
work perfectly well and produce well separable (informa-
tive) clusters corresponding to the three genotype classes
(AA, AG and GG), whereas one probe chemistry, namely
APEX.LEFT, fails to work properly and gives overlapping
clusters for AG and GG genotype classes [plot (3) in Fig.
3]. Nevertheless, this probe chemistry gives a well separa-
ble cluster for the AA genotype class. This phenomenon
conveys the point of considering each probe chemistry
separately during the building of the genotype classifica-
tion model, and in the next stage of the genotype calling
algorithm, combining the four genotype models with
proper weights adjusted dynamically with the quality of
each of the four classifiers (four probe chemistries) spe-
cific to each SNP and sample. If all four probes failed to
produce informative clusters, then our LDA-based geno-
type calling algorithm would flag that SNP as a failed SNP,
which clearly is not the case for the SNP rs12466929. This
is how the redundancy amongst our APEX based genotyp-
ing platform is captured through the proposed LDA-based
genotype calling algorithm with dynamic variable selec-
tion. Viewing the four-panel scatter plots, we would also
like to emphasize the point that for most of the SNPs the
homozygous clusters show some significant signal inten-
sities corresponding to the other allele, due to spectralPage 6 of 15
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thus inducing background to the homozygous clusters.
Particularly for this reason, we do not often see a
homozygous cluster close to either of X- or Y-axes. Here,
the aim is to compare the allele 1 and allele 2 signal inten-
sities for the three possible genotype classes, and then
assign a test sample to the appropriate class based on the
prior knowledge of the available training set. We would
also like to mention that the initial signal intensities cor-
responding to each allele for all four probe chemistries are
converted into the log-scale in order to reduce the variabil-
ity between several microarray slides.
Performance analyses for the different data sets are
described below, addressing the redundant probe chemis-
try. The extreme left hand column of each table indicates
the combination of four classifiers used to build the LDA
model [Additional files 8, 9 and 10]. For example, in the
first row, all four classifiers were used to give the final gen-
otype call, and in the fourth row, only the left classifiers
were used. In the last four rows, only one classifier was
used at a time to give independent genotype calls using
the simple LDA model (with no dynamic variable selec-
tion). For the complete set of 287 HapMap samples and
the set of 41 SNPs, the training data had in total 807 gen-
otype cases (among which 519 genotypes were from Hap-
Map Coriell samples and 288 genotypes were from other
Coriell samples) and the test data had in total 11,248 gen-
otype cases (among which 163 had no validated geno-
types from HapMap for comparison).
Simple scatter plots for SNP rs12466929 (A/G) from 50-plex data set (this SNP is representative of the entire set of 50 Hap-Map SNPs)Figure 3
Simple scatter plots for SNP rs12466929 (A/G) from 50-plex data set (this SNP is representative of the entire set of 50 Hap-
Map SNPs). For each plot the x-axis represents signal values for X allele (A for this SNP) and the y-axis represents signal values 
for Y allele (G for this SNP). All values are in log scale. Magenta, green, blue and black coloured symbols denote the classes YY 
(GG), YX (AG), XX (AA) and NN (negative control samples), respectively. Plot (1) combines the two ASO-APEX Left probes 
(one for each allele); plot (2) combines the two ASO-APEX Right probes (one for each allele); plot (3) is for the APEX Left 
probe; plot (4) is for the APEX Right probe. All the classifiers except APEX Left (plot 3) give well separated genotype clusters 
for this SNP. Dynamic variable selection is able to automatically weight these LDA classifiers in such a way that the 
homozygous AA cluster in plot (3) (blue) is able to contribute to the final call for such genotypes, even though AG (green) and 
GG (magenta) genotype clusters overlap somewhat for this Left APEX probe. Additional file 11 shows four-panel scatter plots 
for all 50 SNPs from the 50-plex data set.
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threshold improved the concordance rate (0.31% miss-
classification rate) with a reduced call rate of 97.30%. We
further checked the performance of the same data set
applying a stringent threshold of 0.75, which gave
99.91% concordance (0.06% miss-classification rate) for
a reduced call rate of 94.91%. Applying different level of
thresholds, we can control the call rates and, given the val-
idated genotype set, we can also check the performance
level by calculating the miss-classification rates. The
underlying supposition is that, with reduced call rate,
accuracy should increase successively until it reaches its
maximum limit. For the improved 50-plex PCR chemistry,
we were able to achieve a high concordance rate (99.89%
using all four classifiers) with 100% call rate [Table 2]. If
we apply a 0.65 threshold to the set of 50-plex PCR Hap-
Map samples, then the automated call rate reduced to
99.18%, leaving only 16 non calls (below threshold
value) to be verified manually using SNP Chart (all of
which were correct).
Therefore, we have determined that reliance on any single
probe type alone [i.e.: APEX Left probe; APEX Right probe;
2 × ASO-APEX Left probes (one for each allele); 2 × ASO-
APEX Right probes (one for each allele)] resulted neither
in as high an accuracy of genotyping nor in as high a call
rate, compared to the dynamic use of multiple probes.
We were interested in further study of the two discrepant
genotype cases, since both had previously been concord-
ant with HapMap in the 7-reaction-multiplex PCR data
set, and both showed high quality, unambiguous SNP
Charts in the 50-plex PCR data set. A third genotype case
(concordant with HapMap by manual calling and simple
LDA, but with a low quality score of 0.4876) was also dis-
crepant when called by MACGT. We re-amplified these
three individual SNP loci from their respective Coriell
DNA samples, using the original PCR primers [Additional
file 1], and sequenced each amplicon from both ends. The
two discrepant genotypes were: 1. DNA sample 192
(NA18502) at SNP rs3776720 – 50-plex genotype GG/
HapMap & 7-reaction-multiplex genotype GA; 2. DNA
sample 101 (NA18621) at SNP rs12472674 – 50-plex
genotype CC/HapMap & 7-reaction-multiplex genotype
CT. The third genotype case (concordant with HapMap by
manual calling and simple LDA, but with a low quality
score of 0.4876) was also discrepant when called by
MACGT (DNA sample 228 (NA19210) at SNP rs4739199
– 50-plex genotype (MACGT) TT/HapMap, 7-reaction-
multiplex, and 50-plex (manual call & LDA) genotype
CT).
As expected, we identified additional polymorphic sites
that coincided with the positions delimited by the PCR
primer sequences used for the 50-plex reaction. One of the
sites was identified as an existing SNP (rs6871885). To
our knowledge, the other two sites represent genetic vari-
ants not previously reported. For each of these cases, it
appears that the sequence variation within the PCR
primer site has caused allelic drop-out, resulting in
homozygous genotype calls for the two discrepant cases,
and a poor quality heterozygous genotype call for the
third case (partial allelic drop-out). Specifically, for dis-
crepant genotype case 1 (Coriell NA18502 at SNP
rs3776720), we found a neighbouring SNP (T/A) which is
located at the 3' end of the anti-sense PCR primer site (5'
CGA TGT AGG TGA CAC TAG TAT TGC AGG CAG ACG
TGA3' – [Additional file 6]) – this polymorphic site (30
bp downstream of rs3776720) is reported in dbSNP as
rs6871885, with the A base (sense strand) being described
as a rare allele (0.083) in sub-Saharan African populations
only (Coriell NA18502 is indeed a sub-Saharan African,
Yoruba, and is heterozygote for this SNP).
For discrepant genotype case 2 (Coriell NA18621 at SNP
rs12472674), we found a sequence variant (G/A) 52 bp
downstream of SNP rs12472674, located within the anti-
sense PCR primer site (5' CGA TGT AGG TGA CAC TAG
CTC AAT ATG TTA CCA CAA 3' – [Additional file 6]) – this
variant (heterozygous in Coriell NA18621 – Asian, Han
Chinese) has not been previously reported in dbSNP and
may represent a novel polymorphism. For the low quality
genotype case 3 (Coriell NA19210 at SNP rs4739199), we
found a sequence variant (G/A) 45 bp downstream of SNP
rs4739199, located within the anti-sense PCR primer site
(5' CGA TGT AGG TGA CAC TAG TCCACT TCA TTA GGT
GAA 3' – [Additional file 6]) – this variant (heterozygous
in Coriell NA19210 – sub-Saharan African, Yoruba) has
also not been previously reported in dbSNP and may rep-
resent a novel polymorphism.
Whilst more stringent due-diligence at the 50-plex PCR
primer design stage would have alerted us to one of these
SNPs (rs6871885), the evidence that we have identified
two hitherto unreported SNPs provides a cautionary tale
[30]. Elimination of such 'sporadic' genotyping errors due
to novel or unaccounted-for SNPs, as well as due to struc-
tural variation in the genome (e.g., copy number variants
– CNVs) [31], will need to be addressed in future clinical
diagnostic genotyping technologies, and possibly even in
research discovery studies where any sporadic errors due
to hidden SNPs will not cause significant departure from
Hardy-Weinberg equilibrium [15]. In preliminary studies
we have been able to correct all three discrepancies previ-
ously described, using a redundant 50-plex PCR assay that
includes two primer pairs for each SNP loci (data not
shown).
Finally, due to the low amount (5 ng) of genomic DNA
required for the 50-plex PCR (compared to 25 ng for eachPage 8 of 15
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APEX genotyping using our improved methodology on
DNA derived from plasma samples. A pilot project was
performed on five plasma samples (stored for up to ten
years). Comparing the plasma-derived genotyping data
with data obtained from high quality genomic DNA for
the same five individuals, the call rate was >99% (100%
for high quality DNA) and the concordance was >99%,
which opens up the possibility of robust and accurate gen-
otyping of clinical plasma samples without any need for
prior whole genome amplification.
Conclusion
We report significant improvements to arrayed primer
extension (APEX) genotyping methodology that may
show utility in future point-of-care genetic diagnostic
applications. Our methods have been validated against
industry-leading technologies in a blinded experiment
based on Coriell DNA samples and SNP genotype data
from the International HapMap Project. Modifications to
PCR amplification design have allowed robust 50-plex
genotyping from as little as 5 ng of DNA, with 100% call
rate and >99.9% accuracy.
Methods
DNA Samples and Validated Genotypes
A set of 287 DNA samples were obtained from McGill
University and Génome Québec Innovation Centre (one
of the HapMap Project's genotyping centers). This set
comprised 270 DNA samples from the Coriell Institute for
Medical Research [22] plus hidden duplicates and nega-
tive controls, all of which our laboratory was blinded to.
We were given access to the validated HapMap genotyping
data for these samples only after we had finished the main
genotyping experiment (287 samples/50 SNPs), and after
we had sent a file of our genotyping results to McGill Uni-
versity.
HapMap APEX Chip – Probe Design and Printing
Six oligonucleotide probes (25 mers) for each SNP were
designed using Biodata algorithms (Biodata Ltd., Tartu,
Estonia [32]) [Additional file 1]: two classical APEX
probes (one probe per DNA strand), plus four allele-spe-
cific (ASO) APEX probes (two probes per strand) which
include the actual SNP site at the 3' end of the probe.
Allele-specific single base extension of these ASO-APEX
probes during the reaction is contingent on the presence
of the actual complementary base at the SNP site in the
sample template DNA [6,10]. Probes were synthesized at
a 25 nmol scale and aliquotted into 96-well plates by Inte-
grated DNA Technologies (Coralville, IA, USA). We
diluted each probe at 200 pmol/µL as stock concentration
in pure water (resistivity of 18.2 MΩ-cm and total organic
content of less than five parts per billion) using a Biomek
FX robot (Beckman Coulter, Fullerton, CA, USA).
Arrays were generously printed for us at the Microarray
Facility of The Prostate Centre at Vancouver General Hos-
pital [33] (University of British Columbia, Vancouver, BC,
Canada). Briefly, the APEX and ASO-APEX probe oligonu-
cleotides (50 pmol/µL in 150 mM sodium phosphate
printing buffer, pH 8.5) were printed to specific grid posi-
tions on CodeLink™ Activated Microarray Slides (Amer-
sham Biosciences/GE Healthcare, Piscataway, NJ, USA)
following the manufacturer's recommended protocols.
The 5' end of each oligonucleotide probe was amino-
modified during synthesis, allowing its covalent attach-
ment to the slide's pre-applied surface chemistry. Each
grid consisted of five spot replicates of each of the six
probes per SNP, as well as multiple buffer-only spots and
positive control normalization spots. The latter comprised
an oligonucleotide probe based on a plant-specific gene
sequence that will extend by a single N base due to the
presence of an exogenous complementary template oligo-
nucleotide in the APEX reaction mixture (Npg1) [14].
Each Npg1 positive control probe was spotted 40 times
onto the grid, at regular physical intervals. Each one of the
six probes for each SNP was printed at a reasonably wide
distance apart from any other probe for the same SNP
within the grid (as were their replicate spots). This ena-
bled a useful degree of robustness in the system, especially
helpful in cases of high local background and hybridiza-
tion problems [14]. Each spot was approximately 110 µm
in diameter. Three replicated grids were printed on each
slide, enabling three samples to be genotyped per slide.
Following the printing of the arrays, the slides were incu-
bated overnight at room temperature at 75% relative
humidity (saturated NaCl chamber) to drive the covalent
coupling reaction between the probes' 5' amino group
and the CodeLink™ slide chemistry to completion. Block-
ing of the arrays was in 50 mM ethanolamine, 0.1 M Tris,
pH 9.0, 0.1% SDS, at 50°C for 20 min, according to the
manufacturer's protocol.
PCR Amplification and Fragmentation
For the first experiment, PCR primers were designed to
amplify the regions across the 50 SNPs, based on a melt-
ing temperature (Tm) of 62°C ± 3°C (at 20 mM monova-
lent salt concentration in PCR buffer [Additional file 1]).
All primers were computationally tested against the
human genome and found to amplify single product (Bio-
data Ltd., Tartu, Estonia [32]). Multiplex PCR amplifica-
tions were performed on the Coriell genomic DNA
samples (plus several negative PCR control samples that
contained no genomic DNA). The multiplex PCR group
had a unique combination of the primer pairs among 7
reactions [Additional file 2]. Each PCR was performed in
a total volume of 15 µL, containing 1.5 µL 10× PCR buffer
[Tris-Cl, (NH4)2SO4, 15 mM MgCl2, pH 8.7], 1.5 mM
MgCl2, 200 µM dNTPs without dTTP, 160 µM dTTP, 40µM dUTP, 0.75 U HotStar Taq DNA polymerase (5 U/µL;Page 9 of 15
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(each primer), and 25 ng genomic DNA. Incorporation of
the dUTP allowed for the amplified DNA to be enzymati-
cally sheared by uracil N-glycosylase (UNG, InterScience,
Troy, NY, USA) to produce a DNA size of approximately
50–100 bases, optimal for hybridization to the oligonu-
cleotides on the microarray (see below). Genomic DNA
and PCR master mixture were transferred into ABI 384-
well reaction plates (Applied Biosystems, Foster City, CA,
USA) using a Biomek FX robot (Beckman Coulter, USA).
PCR reactions were performed in a GeneAmp PCR System
9700 ThermoCycler (Applied Biosystems, USA). PCRs
were initiated by a 15 min polymerase activation step at
95°C and completed by a final 10 min extension step at
72°C. The PCR cycles were as follows: 35 cycles of 30 s
denaturation at 95°C, 30 s annealing at 58°C, and 50 s
extension at 72°C.
For the second experiment, in order to increase the effi-
ciency of PCR, we designed 50× 5' linker PCR primer pairs
[Additional file 6] based on a Tm of 65°C ± 7°C and per-
formed 50-plex PCR in one single reaction per sample.
Each new PCR primer had a common linker sequence
designed at its 5' end (5' TACGACTCACTTAGGGAG-3' for
each of the left hand PCR primers/5' CGATGTAGGT-
GACACTAG-3' for each of the right hand PCR primers).
The 3' ends of the primers were chosen to have non-com-
plementary bases with respect to each other (i.e., all prim-
ers ended with one or two A bases), in order to reduce the
probability of primer interactions and primer-dimer for-
mation. All primers were computationally tested against
the human genome and found to amplify single product.
The new amplicon sequences were located within the
amplicon sequences from the original primer pairs. The
multiplex PCR was carried out in a 25 µL reaction contain-
ing 20 nM (final) of each primer plus 20 nM of left and
right linker-only primers (left linker: 5' TACGACTCACT-
TAGGGAG 3'/right linker: 5' CGATGTAGGTGACACTAG
3'), 200 µM dNTPs without dTTP, 160 µM dTTP, 40 µM
dUTP, 6 units of HotStar Taq DNA polymerase (5 U/µL;
Qiagen, USA), 1.5 mM MgCl2 in 1× PCR reaction buffer
[100 mM Tris-HCl, 50 mM KCl, 100 µg/mL Gelatin, pH
8.3] with 5 ng of genomic DNA. PCR was performed using
a MJR PTC 200 ThermoCycler (MJ Research, Waltham,
MA, USA). PCR was initiated by a 15 min polymerase acti-
vation step at 95°C and completed by a final 3 min exten-
sion step at 72°C. The reaction procedure consisted of 40
cycles of denaturation at 95°C for 40 s, primer annealing
at 55°C for 2 min and one ramping-up step from 55°C to
70°C for 2.5 min (0.1°C/s) [28].
Aliquots of PCR products were visualized with Gel Red
fluorescent nucleic acid dye (Biotium, Hayward, CA, USA)
staining under ultraviolet (UV) illumination on a 2% aga-
rose gel, following electrophoresis in 0.5× Tris-borate
EDTA (TBE) buffer. The 7 subgroup multiplex PCR prod-
ucts were pooled for each individual Coriell sample and
precipitated by adding 2.5 volumes of ice-cold 100% eth-
anol and 0.25 volumes of 10 M ammonium acetate solu-
tion. After precipitation at -20°C overnight, the mixture
was centrifuged at 20,800 × g at 4°C for 20 min. The
supernatant was carefully removed, and the DNA pellet
was washed with 400 µL of ice-cold 70% ethanol. The
DNA pellet was then dissolved in 15 µL pure water. 10 µL
of this DNA (or 10 µL of unpurified 50-plex PCR prod-
ucts; amplified to a concentration of approximately 300 –
400 ng/µL.) were then fragmented by 1 U uracil-N-glyco-
sylase (UNG; Inter Science Inc., Troy, NY, USA) and unin-
corporated dNTPs were simultaneously inactivated by
digestion with 1 U shrimp alkaline phosphatase (SAP;
Amersham Biosciences/GE Healthcare, USA) for 15 min
at 37°C, in a 20 µL reaction mixture containing 2 µL 10×
digestion buffer [0.5 M Tris-HCl, 0.2 M (HN4)2SO4,
pH9.0], followed by enzyme inactivation for 10 min at
95°C.
Microarray-based Minisequencing: Arrayed Primer 
Extension (APEX)
The APEX reaction was performed in a total volume of 40
µL by the addition of 17 µL fragmented DNA template, 1
µL of 2 pmol/µL Npg1-positive control template oligonu-
cleotide, 1.25 µM of each fluorescently labeled dideoxy-
nucleotide triphosphate (Texas Red-ddATP, Cy3-ddCTP,
Cy5-ddGTP, R110-ddUTP; Perkin Elmer Life Sciences,
Boston, MA, USA), 5 U Thermo Sequenase™ DNA
polymerase (Amersham Biosciences/GE Healthcare, USA)
diluted in its dilution buffer, 2× Thermo Sequenase reac-
tion buffer [10×, 260 mM Tris-HCl, 65 mM MgCl2, pH
9.5]. The reaction mixture was applied to the grid of APEX
and ASO-APEX probes previously printed on the Code-
Link slide that had been washed two times in 95°C pure
water and placed on a Thermo Hybaid HyPro20 incuba-
tion plate (Thermo Electron, Waltham, MA, USA) set at
58°C. The reaction mixture was covered with a small piece
of Parafilm™, and the APEX reaction allowed to proceed at
58°C with agitation (setting 1) for 20 min. Following the
incubation period, slides were washed with 95°C water to
remove the template DNA, enzyme, and excess ddNTPs.
Further washing in 0.3% Alconox (Alconox Inc., White
Plains, NY, USA) and 95°C pure water ensured low back-
ground on the array images.
DNA Sequencing
As described in the main paper, we directly sequenced
three SNP loci in three independent samples: 1. sample
192 (NA18502) at SNP rs3776720; 2. sample 101
(NA18621) at SNP rs12472674; 3. sample 228
(NA19210) at SNP rs4739199. We performed three sin-
gle-plex PCR reactions using primer pairs from the first
experimental design and methods [Additional file 1] toPage 10 of 15
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these three Coriell DNA samples. PCR primers pairs used
were: 1. rs3776720 sense 5' GGC CAA GGA AAA GAA
ATG AAT CTG CT 3', anti-sense 5' AAC TTT AGT GCA
GGA TTT GCC ATC CA 3' – PCR amplicon size of 389 bp;
2. rs12472674 sense 5' TAA AAT CCA ATC AGG CCA ACT
GTT CA 3', anti-sense 5' TCA ATG CCA TTA TAT GTG CCA
GCC A 3' – PCR amplicon size of 388 bp; 3. rs4739199
sense >5' TCC AGC CAG CAA AAG ATC CTC AAA 3', anti-
sense 5' TCA AGC ACA TGT TAC CAG TTT CCC AA 3' –
PCR amplicon size of 587 bp. PCR products were purified
using a QIAquick PCR Purification Kit (Qiagen, Valencia,
CA, USA) according to the manufacture's instructions.
DNA sequencing reactions were performed by the Nucleic
Acid Protein Service Unit [34] at the University of British
Columbia (Vancouver, BC, Canada). For each amplicon,
sense and anti-sense PCR primers were used as sequencing
primers.
Microarray Imaging and Spot Intensity Calculation
Slide microarrays were imaged using an arrayWoRxe Auto
Biochip Reader (Applied Precision, LLC, Issaquah, WA,
USA), fitted with the following filter sets: 1. A488 – Ex.
480/15× – Em. 530/40 (R110 dye); 2. Cy3 (narrowband)
– Ex. 546/11 – Em. HQ570/10 m (Cy3); 3. Texas Red – Ex.
602/13 – Em. 631/23 (Texas Red); 4. Cy5 – Ex. 635/20 –
Em. 685/40 (Cy5) (Chroma Technology, Rockingham,
VT, USA). Exposure times for each dye were set up to give
approximately 60–70% pixel saturation for selected Npg1
positive control probe spots. Resolution of the imager was
set to 10 µm. Four 16-bit TIFF files for each array were
obtained (one from each channel) and these were
imported into SNP Chart [35], a data management and
visualization tool for array-based genotyping by primer
extension from multiple probes [23]. This software gener-
ates visual patterns of spot intensity values, from multiple
channels across a multiple probe set specific for a given
SNP, allowing easy calling of the genotype. All the images
were gridded in SNP Chart by manually selecting four pre-
defined spots that, combined with knowledge of the lay-
out of the grid, allows SNP Chart to locate every spot [23].
Spot segmentation and background subtraction were
based on hybrid segmentation algorithms previously pub-
lished by our laboratory [24,25]. Spot intensity values
were normalized by setting the 40 Npg1 positive control
spots, widely distributed across each array grid, to an aver-
age value of 20,000 units per channel, with the exported
normalized intensity value calculated from the scale factor
× median signal) [16].
Genotyping – Manual Calling
Manual genotype calling within SNP Chart was carried
out as previously described [14,16,23].
Genotyping – Automated Calling Using MACGT
The training set for MACGT (multi-dimensional auto-
mated clustering genotyping tool) [17] was selected by
manually inspecting SNP Charts for each of the SNPs
across some of the 287 samples. For the 50 SNPs, up to ten
high-quality charts were chosen as 'prototypes' [23] for
each genotype. All prototype data were exported from
SNP Chart into a format readable by MACGT. MACGT
was run on just the training data, and the clusters for each
SNP were manually inspected to ensure there where no
errors in the training set. Genotyping was performed by
MACGT using the parameters
NORMALIZE_GROUP_OF_4 = 1,
GROUP_OF_4_MEAN_CUTOFF = 10,
PATCH_GROUPS_OF_4 = 1, DROP_NNS = 1 [17]. A 'fit'
statistical cut-off of 0.001 was used to identify poor qual-
ity genotypes as non-calls (NNs) [17]. Any SNP or sample
with a high rate of NNs was subject to further inspection.
We identified nine SNPs that the PCR assay performed
poorly on and which MACGT could not confidently score,
although manual inspection of SNP Charts did show that
the assays were somewhat successful, albeit non-repro-
ducibly. The final training set for the 41 SNPs was made
up of 519 genotypes [Additional file 3]. All NNs were
inspected within SNP Chart and manually called if possi-
ble. The final genotypes from MACGT and from those
manually called were combined, and compared to the val-
idated genotypes from HapMap using a Microsoft Excel
macro [Additional file 3].
Genotyping – Automated Calling Using Simple LDA with 
Dynamic Variable Selection
Detailed descriptions of the algorithms used in simple lin-
ear discriminant analysis (LDA) with dynamic variable
selection have previously been published by our labora-
tory [18]. A brief descriptive example follows, using the
data structure for SNP rs12466929 and DNA sample 101
(Coriell NA18621 – genotype AA [Additional file 12]).
Ideally, for variable construction, each genotype call could
be based on just one of the four sets of probes: (1)
APEX_LEFT; (2) APEX_RIGHT; (3) ASO_1LEFT and
ASO_2LEFT; and (4) ASO_1RIGHT and ASO_2RIGHT
[Additional file 12]. Considering the underlying chemis-
try, we have developed four sets of classifiers, named:
APEX.L, APEX.R, ASO.L and ASO.R. Each of these classifi-
ers consists of a pair of explanatory variables, generically
denoted by X and Y, corresponding to two candidate alle-
les in the SNP position [Additional file 13]. In Additional
file 12, for example, X and Y correspond to the A and G
alleles, respectively. Since there are five realizations (repli-
cates) for each of the two entries in each classifier, we
summarized the information for each allele, by taking a
robust average: median of the relevant signals from five
spots, for each of the classifiers. From the example data inPage 11 of 15
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sifier APEX.L are
APEX.XL = median (1394, 1148, 597, 1106, 1504) =
1148, and
APEX.YL = median (29, 27, 43, 27, 32) = 29, and so on, as
summarized in Additional file 13. In our subsequent anal-
yses, we have considered different combinations of the
above mentioned classifiers.
Our automated genotype calling algorithm is based on
the simple linear discriminant analysis (LDA), using
dynamic variable selection as special criteria for various
classifiers related to multiple probes. LDA is a supervised
learning technique which requires a valid training set in
order to build the classification (genotyping) model for
each SNP. For the complete set of 287 HapMap samples,
our dynamic variable LDA-based genotype calling algo-
rithm used the same training set as used by MACGT above
(i.e., 519 genotypes across the 41 SNPs [Additional file 3])
and predicted the genotypes for the remainder of the sam-
ples.
For LDA analysis of the 50-plex PCR chemistry, performed
on a subset of 50 HapMap samples which were chosen
randomly out of the original 287 samples, we selected
prototypes to build a new training set using MACGT clus-
ters, verifying the chosen cases with SNP Chart. We con-
sidered two different training sets, one with a small
number of prototypes (at most 3 to 4 prototypes in each
class) and the other with a minimal number of prototypes
(at most 2 prototypes in each class) for each SNP. The two
different training sets yielded different performances for
the respective test data sets.
For automated genotype calling, we started our analysis
by fitting the simple LDA-based genotype model using
each classifier separately, and then comparing the pre-
dicted genotypes with the validated genotypes. Subse-
quently, we applied our dynamic-variable LDA-based
genotyping model on different combinations of the four
classifiers. When combining four classifiers together, for
each SNP we apply LDA to each pair of variables in Addi-
tional file 13. For generic alleles X and Y, the possible
classes are XX, XY, YY and NN (NN class corresponding to
negative controls: generally low signal intensities for all
channels throughout all probes). Bayesian posterior prob-
abilities for the possible classes from each of the four pos-
sible classifiers are given in Table 3. The posterior
probabilities for the four classifiers are combined using an
entropy-based weighting scheme. For example, for the
ASO.L classifier, define
Analogous quantities are computed for other classifiers
EASO.R, EAPEX.L and EAPEX.R
Proper weights are obtained by normalizing them, e.g.,
The weights are applied to the posterior probabilities of
the respective class to give the final class posterior proba-
bilities. For example, the final posterior probability for XX
class is
After obtaining PXY, PYY and PNN in a similar manner, the
final genotype call is obtained with highest weighted
probability. In the last stage, call rate can be adjusted by
applying varying thresholds to the 'final weighted proba-
bility' (confidence score), and the concordance with the
validated genotype set will vary accordingly. The calls
were checked for concordance with the validated geno-
types from HapMap.
Additional file 7 contains all 50-plex HapMap genotyping
data, for both MACGT and LDA.
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Table 3: Bayesian posterior probabilities for the possible classes 
from each of the four possible classifiers
LDA/Classes XX XY YY NN
ASO.L Pxx (ASO.L) Pxy (ASO.L) Pyy (ASO.L) PNN (ASO.L)
ASO.R Pxx (ASO.R) Pxy (ASO.R) Pyy (ASO.R) PNN (ASO.R)
APEX.L Pxx (APEX.L) Pxy (APEX.L) Pyy (APEX.L) PNN (APEX.L)
APEX.R Pxx (APEX.R) Pxy (APEX.R) Pyy (APEX.R) PNN (APEX.R)Page 12 of 15
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Additional file 1
List of SNPs, probes and PCR primers. Table that details the rs numbers 
of the 50 SNPs investigated, as well as the APEX and allele-specific APEX 
probe sequences, and the PCR primer sequences for the initial experiment.




PCR multiplex groups. Table that details the 7 groups of multiplex PCRs.




Genotyping results from first experiment. Table that lists the complete gen-
otyping results for 287 HapMap samples and 41 SNPs. Includes LDA call 
and MACGT call (with quality scores), as well as original HapMap call.




SNP Charts showing high quality genotypes (auto-called correctly) and 
lower quality genotypes (auto-called 'NN', but manually-called correctly). 
Chart interpretation is given below. Illustrative examples for each geno-
type case (TT, TC, CC) are shown for the SNP rs1433375. SNP Charts 
on the left hand side (samples 104, 148 and 67) represent auto-called 
genotypes, whilst those on the right hand side (samples 125, 128 and 
126) represent manually-called genotypes. The y-axes (signal intensity) of 
each individual genotype class have been set to identical scale values for 
both auto- and manually-called samples, and clearly show that genotypes 
can be correctly called (at least by manual inspection of the data) from 
samples having signal intensities up to an order of magnitude lower than 
usual. Each chart shows four channel fluorescent intensity data (A,C,G 
and T) from thirty rs1433375-specific array spots (five replicate spots for 
six different probes – arranged along x-axis). Starting at the left hand side 
of each chart, the first five spots ('LEFT T/C') refer to the left-hand APEX 
probe that will give either a single T (blue) signal (for homozygous TT 
genotypes), or a C (green) signal (for homozygous CC genotypes), or a 
mixture of T and C (heterozygous CT). The next five spots ('RIGHT A/
G') refer to the right-hand APEX probe that interrogates the complemen-
tary DNA strand nucleotide to that of the left-hand APEX probe, hence 
gives a single A (yellow) signal (for TT), a single G (red) signal (for CC), 
or a mixed A and G signal (for TC). The remaining spots represent allele-
specific APEX probes in which a base-specific fluorescence signifies the 
presence of the allele. '_1' probes correspond to the first allele (T in the 
case of rs1433375), and '_2' probes correspond to the second allele (C). 
The redundancy and consistency of the data across different probes give 
high confidence in the assigned genotypes.




Re-scaled SNP Charts for rs1433375. This figure is a repeat of Additional 
file 4, except that the y-axes of the SNP Charts on the right hand side 
(manually-called samples) have been adjusted to show as much of the spot 
intensity data as possible. Note the relative increases in the background 
signals, as compared to the chart data on the left hand side (auto-called 
samples).




List of PCR primer sequences for 50-plex PCR experiment. PCR primer 
sequences that were designed for the 50 HapMap SNP loci, with amplicon 
sizes restricted to between 100 and 200 bp, and with common 5' linkers.




Genotyping results from second experiment (50-plex PCR). Table that 
lists the complete genotyping results for 49 HapMap samples and 50 
SNPs. Includes LDA call and MACGT call (with quality scores), as well 
as original HapMap call.




Performance analyses for the different data sets, addressing the redundant 
probe chemistry. To further determine the effect of probe redundancy in 
our APEX methodology, we used LDA to reanalyze both data sets (original 
and 50-plex) but using non-redundant and partially-redundant probe-
specific data. Three tables are shown (8, 9 and 10).
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and black coloured symbols denote the classes YY, YX, XX and NN (neg-
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Left probes (one for each allele); plot (2) combines the two ASO-APEX 
Right probes (one for each allele); plot (3) is for the APEX Left probe; plot 
(4) is for the APEX Right probe. The plots for SNPs rs3776720, 
rs12472674 and rs4739199 include labeled data-points for the individ-
ual Coriell samples that gave rise to discrepancies in genotype calling.




Data structure for SNP rs12466929 & DNA sample HapMap 101 (Cori-
ell NA18621 – AA). Illustrative table of microarray four-channel inten-
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List of explanatory variables listed by appropriate classifiers. Each of these 
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Click here for file
[http://www.biomedcentral.com/content/supplementary/1755-
8794-1-5-S13.pdf]Page 14 of 15
(page number not for citation purposes)
BMC Medical Genomics 2008, 1:5 http://www.biomedcentral.com/1755-8794/1/5Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
congenital amaurosis: detection of modifier alleles.  Invest
Ophthalmol Vis Sci 2005, 46(9):3052-3059.
21. Jaakson K, Zernant J, Kulm M, Hutchinson A, Tonisson N, Glavac D,
Ravnik-Glavac M, Hawlina M, Meltzer MR, Caruso RC, Testa F,
Maugeri A, Hoyng CB, Gouras P, Simonelli F, Lewis RA, Lupski JR,
Cremers FP, Allikmets R: Genotyping microarray (gene chip)
for the ABCR (ABCA4) gene.  Hum Mutat 2003, 22(5):395-403.
22. Coriell Institute for Medical Research   [http://coriell.org/]
23. Tebbutt SJ, Opushnyev IV, Tripp BW, Kassamali AM, Alexander WL,
Andersen MI: SNP Chart: an integrated platform for visualiza-
tion and interpretation of microarray genotyping data.  Bioin-
formatics 2005, 21(1):124-127.
24. Abbaspour M, Abu-Gharbieh R, Podder M, Tebbutt SJ: Fully-auto-
mated analysis of multi-resolution four-channel microarray
genotyping data.  2006, 6144:61443M 1-8.
25. Abbaspour M, Abu-Gharbieh R, Podder M, Tripp BW, Tebbutt SJ:
Hybrid spot segmentation in four-channel microarray geno-
typing image data: Vancouver, Canada.   ; 2006:M21.3. 
26. Wang DG, Fan JB, Siao CJ, Berno A, Young P, Sapolsky R, Ghandour
G, Perkins N, Winchester E, Spencer J, Kruglyak L, Stein L, Hsie L,
Topaloglou T, Hubbell E, Robinson E, Mittmann M, Morris MS, Shen
N, Kilburn D, Rioux J, Nusbaum C, Rozen S, Hudson TJ, Lander ES,
et al.: Large-scale identification, mapping, and genotyping of
single-nucleotide polymorphisms in the human genome.  Sci-
ence 1998, 280(5366):1077-1082.
27. Brownie J, Shawcross S, Theaker J, Whitcombe D, Ferrie R, Newton
C, Little S: The elimination of primer-dimer accumulation in
PCR.  Nucleic Acids Res 1997, 25(16):3235-3241.
28. Wang HY, Luo M, Tereshchenko IV, Frikker DM, Cui X, Li JY, Hu G,
Chu Y, Azaro MA, Lin Y, Shen L, Yang Q, Kambouris ME, Gao R, Shih
W, Li H: A genotyping system capable of simultaneously ana-
lyzing >1000 single nucleotide polymorphisms in a haploid
genome.  Genome Res 2005, 15(2):276-283.
29. Smemo S, Borevitz JO: Redundancy in genotyping arrays.  PLoS
ONE 2007, 2:e287.
30. Quinlan AR, Marth GT: Primer-site SNPs mask mutations.  Nat
Methods 2007, 4(3):192.
31. Feuk L, Carson AR, Scherer SW: Structural variation in the
human genome.  Nat Rev Genet 2006, 7(2):85-97.
32. Biodata Ltd., Tartu, Estonia   [http://www.biodata.ee/]
33. Microarray Facility of The Prostate Centre - at Vancouver
General Hospital   [http://www.microarray.prostatecentre.com/]
34. Nucleic Acid Protein Service Unit at the University of British
Columbia   [http://www.michaelsmith.ubc.ca/services/NAPS/]
35. SNP Chart - Single Nucleotide Polymorphism Genotyping
Software   [http://www.snpchart.ca]
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1755-8794/1/5/prepubPage 15 of 15
(page number not for citation purposes)
